These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2889438)

  • 1. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality.
    Waddington JL; Youssef HA; Dolphin C; Kinsella A
    Arch Gen Psychiatry; 1987 Oct; 44(10):907-12. PubMed ID: 2889438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?
    Waddington JL; O'Callaghan E; Larkin C; Kinsella A
    Brain Cogn; 1993 Sep; 23(1):56-70. PubMed ID: 8105822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1986 Sep; 143(9):1162-5. PubMed ID: 2875664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.
    Gureje O
    J Neurol Neurosurg Psychiatry; 1988 Dec; 51(12):1525-30. PubMed ID: 2906088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vulnerability to involuntary movements over a lifetime trajectory of schizophrenia approaches 100%, in association with executive (frontal) dysfunction.
    Quinn J; Meagher D; Murphy P; Kinsella A; Mullaney J; Waddington JL
    Schizophr Res; 2001 Apr; 49(1-2):79-87. PubMed ID: 11343867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late onset involuntary movements in chronic schizophrenia: relationship of 'tardive' dyskinesia to intellectual impairment and negative symptoms.
    Waddington JL; Youssef HA
    Br J Psychiatry; 1986 Nov; 149():616-20. PubMed ID: 2880630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia.
    Waddington JL; Youssef HA; Kinsella A
    Psychol Med; 1990 Nov; 20(4):835-42. PubMed ID: 1980953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in bipolar affective disorder: aging, cognitive dysfunction, course of illness, and exposure to neuroleptics and lithium.
    Waddington JL; Youssef HA
    Am J Psychiatry; 1988 May; 145(5):613-6. PubMed ID: 2895985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW; White T
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
    Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
    Liddle PF; Barnes TR; Speller J; Kibel D
    Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective awareness of abnormal involuntary movements in schizophrenia.
    Sandyk R; Kay SR; Awerbuch GI
    Int J Neurosci; 1993; 69(1-4):1-20. PubMed ID: 7916006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
    Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of the course of tardive dyskinesia in patients receiving neuroleptics.
    Bergen J; Kitchin R; Berry G
    Biol Psychiatry; 1992 Oct; 32(7):580-94. PubMed ID: 1360260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia.
    Waddington JL; Youssef HA
    Psychol Med; 1996 Jul; 26(4):681-8. PubMed ID: 8817702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlates of distinct topographies of tardive dyskinesia in schizophrenia.
    Waddington JL; Youssef HA; Kinsella A
    Am J Psychiatry; 1993 Nov; 150(11):1757-8. PubMed ID: 8105709
    [No Abstract]   [Full Text] [Related]  

  • 18. Abnormal involuntary movements in patients on long-acting neuroleptics.
    Oyewumi LK; Lapierre YD; Gray R; Batth S; Gelfand R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):719-23. PubMed ID: 6141614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akathisia variants and tardive dyskinesia.
    Barnes TR; Braude WM
    Arch Gen Psychiatry; 1985 Sep; 42(9):874-8. PubMed ID: 2864031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and type II schizophrenia.
    Davis EJ; Borde M; Sharma LN
    Br J Psychiatry; 1992 Feb; 160():253-6. PubMed ID: 1347240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.